In newly diagnosed HGG patients, Thaler et al. [61] showed that the probability of having a VTE ranged between 3.3 and almost 40% when considering cancer-related factors (e.g., leukocyte and platelet count, P-selectin, prothrombin-fragment 1 + 2, FVIII activity, and D-dimer). The gene discussed is F8; the disease is cancer.